Recombinant CD22 (Pinatuzumab Biosimilar) anticorps

N° du produit ABIN7093048

L’anticorps Humanized Monoclonal anti-CD22 (Pinatuzumab Biosimilar) a été validé pour ELISA. Il convient pour détecter CD22 (Pinatuzumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant CD22 (Pinatuzumab Biosimilar) anticorps (ABIN7093048)

Antigène: CD22 (Pinatuzumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp CD22 (Pinatuzumab Biosimilar) est non-conjugé

Application: ELISA

Classe de qualité: Research Grade

Détail du produit anti-CD22 (Pinatuzumab Biosimilar) anticorps

Fonction: Anti-CD22 (pinatuzumab biosimilar) mAb

Attributs du produit: ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Information d'application

Indications d'application: ELISA 1:5000-10000

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur CD22 (Pinatuzumab Biosimilar)

Antigène: CD22 (Pinatuzumab Biosimilar)

Classe de substances: Biosimilar

Sujet: Synonyms: CD22, SIGLEC2, BL-CAM, SIGLEC-2, Siglec2, SIGLEC2FLJ22814

ID gène: 933

UniProt: P20273